Lupus Management After Failure of First-Line Treatment
There are no detailed recommendations agreed upon by SLE experts on what treatment to use after first and second (and often third) line treatment has failed.
There are no detailed recommendations agreed upon by SLE experts on what treatment to use after first and second (and often third) line treatment has failed.
If you’re going to spend 10-20% of your clinic hours examining and caring for 28 or 68 or 360 joints – it may be instructive to own up to those joints we excel at and take note of the ones we avoid, despise or struggle with.
I was recently asked, “what is the best kind of arthritis to have?” My response is based on diagnosibility, treatability and safety of necessary treatment.
In 2012, a Medscape survey of US physicians revealed rheumatology as the most satisfying of medical specialties. This came as a surprise to many as rheumatologists see themselves as the Rodney Dangerfields of medical specialists.
Patient on bisphosphonates for several years, later placed on denosumab. After her 2nd dose, she developed ONJ. Patient then placed on daily teriparatide with resolution of ONJ and now has a normal BMD. She is about to complete her 2nd year of PTH therapy. What should she be treated with after PTH?
While the FRAX is useful to determine if individuals with low bone mass may benefit from treatment for osteoporosis, this method also has some shortcomings.